# DABIGATRAN ETEXILATE MESYLATE
> **ANDA208057** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2017-04-19
## Drug
- **FDA Application Number:** ANDA208057
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DABIGATRAN ETEXILATE MESYLATE
- **Generic name:** Dabigatran Etexilate Mesylate
- **Active ingredients:** DABIGATRAN ETEXILATE MESYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2017-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208057)
---
*MORVS · CC0 1.0*